v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 53,435 $ 26,846 $ 107,119 $ 46,633
General and administrative 10,113 3,817 20,932 7,573
Total operating expenses 63,548 30,663 128,051 54,206
Loss from operations (63,548) (30,663) (128,051) (54,206)
Other income, net:        
Interest income 2,349 688 4,821 1,499
Other income, net 1,007 130 2,370 522
Net loss $ (60,192) $ (29,845) $ (120,860) $ (52,185)
Net loss per share - basic $ (1.32) $ (39.11) $ (2.66) $ (68.46)
Net loss per share - diluted $ (1.32) $ (39.11) $ (2.66) $ (68.46)
Weighted-average number of common shares outstanding - basic 45,431,359 763,044 45,354,488 762,325
Weighted-average number of common shares outstanding - diluted 45,431,359 763,044 45,354,488 762,325
Comprehensive loss:        
Net Income (Loss) $ (60,192) $ (29,845) $ (120,860) $ (52,185)
Other comprehensive loss:        
Unrealized loss on available-for-sale investments (61) (35) (716) (113)
Comprehensive loss $ (60,253) $ (29,880) $ (121,576) $ (52,298)